CatS inhibition has been well studied in some tumor cells, brain tumors (glioblastoma) [60], oral cancer [66], bladder cancer [63], gastric cancer [67], breast cancer, colon cancer, follicular lymphoma, and non-Hodgkin lymphoma [68,69,70,71,72]. Here, PIMREG is linked to neoplasm.